|
| Sanofi-Aventis arrhythmia drug Multaq approved |
2 Jul 09, 22:27 |
|
| Sanofi-Aventis SA said Thursday its drug Multaq, which treats irregular heart rhythms, received marketing approval from the Food and Drug Administration, which turned it down three years ago. |
| more |
|
